SuperworthBenitec Biopharma shares outstanding BNTC
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 49.4M
- On a year earlier
- +20.1%
- more shares
Benitec Biopharma had 49.4M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 20.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 49.4M | +20% |
| FY2025 | 41.2M | +361% |
| FY2024 | 8.9M | +442% |
| FY2023 | 1.6M | +242% |
| FY2022 | 480.7K | +16% |
| FY2021 | 415.7K | +543% |
| FY2020 | 64.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 49.4M | +20% | |
| Q3 FY26 | 49.4M | +28% | |
| Q2 FY26 | 46M | +23% | |
| Q1 FY26 | 41.5M | +49% | |
| Q4 FY25 | 41.2M | +361% | |
| Q3 FY25 | 38.6M | +111% | |
| Q2 FY25 | 37.3M | +1346% | |
| Q1 FY25 | 27.9M | +1193% | |
| Q4 FY24 | 8.9M | +442% | |
| Q3 FY24 | 18.3M | +1011% | |
| Q2 FY24 | 2.6M | +59% | |
| Q1 FY24 | 2.2M | +238% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Benitec Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.